Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease

NCT01036802 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Difficulty in accruing subjects

Conditions

Pulmonary Hypertension

Interventions

DRUG: Warfarin
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]